首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺癌肿瘤标志物的研究进展
引用本文:苏文珍,;武云,;朱巍,;彭志平,;吴金柱[综述],;胡江[审校].肺癌肿瘤标志物的研究进展[J].疾病监测与控制杂志,2009(9):569-569.
作者姓名:苏文珍  ;武云  ;朱巍  ;彭志平  ;吴金柱[综述]  ;胡江[审校]
作者单位:[1]内蒙古医学院,内蒙古呼和浩特010059; [2]包头市中心医院肿瘤内科,内蒙古包头014040; [3]包头市中心医院检验科,内蒙古包头014040; [4]包头市中心医院、包头医学院肿瘤防治研究所,内蒙古包头014040
摘    要:癌胚抗腺(CEA)、糖类抗原-125(CM25)、糖类抗原-199(CA199)在肺癌的诊断、疗效监测及预后方面有重要的临床价值。本研究对CEA、CA125、CA199的研究作一综述。

关 键 词:肿瘤标志物  肺癌  癌胚抗原  糖类抗原-125  糖类抗原-199

Progress Of Serum Tumor Markers Of Lung Cancer
Institution:Su Wen-zhen, WU Yun, ZHU Wei, et al ( 1.Postgraduate In Grade 2007 Inner Mongolia College, Huhhot 010059, China; 2.Baotou Medical College Instiute for Cancer Research Center, The Baotou Central Hospital, Baotou 014040 China; 3.Department of Medical Oncology, The Baotou Central Hospital, Baotou 014040, China; 4.Department of Inspection, The Baotou Central Hospital Baotou 014040, China)
Abstract:The serum tumor markers levels ofCEA, CA125, CA199 were of important value in lung cancer patients on diagnosis, predict response to treatment and evaluate the prognosis.In this paper, we review present status and progress oftheCEA, CA125, CA199.
Keywords:Tumor marker  Lung cancer: CEA  CA125:CA199
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号